One page, the whole story.
Mangalam Drugs And Organics Limited
NSE: MANGALAMHealthcare₹51 Cr
“Malaria niche crushed under governance debris.”
₹31.97
-0.03%₹0.01 today
Day low ₹31.51Day high ₹33.45
Market view
our read, in one sentence, with the evidence one tap awayEODconviction recomputed 21:31No clear market view today
The signals we track (volume, delivery, price trend, deals, breadth and flows) aren't aligned for MANGALAM today. That isn't bearish, just inconclusive.
Why now
today's active factors, delivery data and signals worth reviewingMACD Bullish
MACD is above signal line with positive momentum
Moderatesignal strength
Safety checks
India-specific risk checks.
Activity
filings, bulk and block deals, earnings and other events around this stockBusiness quality
the company itself, each lens scored and explained: a separate read from the Market Setup aboveEODfundamentals to FY27 Q120
The fundamentals carry real weak spots
Four fundamentals lenses on the company itself: valuation, growth, returns & margins, and financial health, judged against the stock's sector. A separate read from the Market Setup above.
0 pass1 neutral3 fail
ValuationFAIR
50
Fairly valued
₹1,000 invested here buys about ₹833 of annual profit. A cheaper stock would buy more.
GrowthDECLINING
0
Growth is soft or negative
Returns & MarginsWEAK
0
Weak returns and margins
Financial HealthSTRAINED
30
Balance sheet under strain
Financials
income, balance sheet, cash flow, dividends and corporate actionsEODaudited to FY27Concalls
management commentary from earnings calls, summarisedEODlatest call 30 Jun '26Filings
exchange disclosures summarised as they are filed✦ AI summary: about 30s after the exchangePeers
how the stock stacks up against its closest listed comparablesEODprices end-of-dayData as of 17 Sept 2026, 9:31 pm